Ontology type: schema:ScholarlyArticle Open Access: True
2013-11-21
AUTHORSJean-François Timsit, Elie Azoulay, Muriel Cornet, Jean-Pierre Gangneux, Vincent Jullien, Aurélien Vésin, Edith Schir, Michel Wolff
ABSTRACTBackgroundThe potential interest of antifungal treatment of non-immunocompromized patients with sepsis, extra-digestive Candida colonization and multiple organ failure is unknown. It represents three-quarters of antifungals prescribed in Intensive Care Units. It may allow early treatment of invasive fungal infection in the incubation phase but expose patients to unnecessary antifungal treatments with subsequent cost and fungal selection pressure. As early diagnostic tests for invasive candidiasis are still considered to be insufficient, the potential interest in this strategy needs to be demonstrated.MethodsThis prospective multicenter, double blind, randomized-controlled trial is conducted in 23 French Intensive Care Units. All adult patients, mechanically ventilated for more than four days with sepsis of unknown origin and with at least one extradigestive fungal colonization site and multiple organ failure are eligible for randomization. Patients with proven invasive candidiasis are not included. After a complete mycological screening, patients are allocated to receive micafungin 100 mg intravenously once a day or placebo for 14 days. We plan to enroll 260 patients. The main objective is to demonstrate that micafungin increases survival of patients without invasive candidiasis at day 28 as compared to placebo. Other outcomes include day 28 and 90 survival and organ failure evolution. Additionally, pharmacokinetics of micafungin in enrolled patients will be measured and evolution of fungal biomarkers and susceptibility profiles of infecting fungi will also be followed.DiscussionThis study will help to provide guidelines for treating non-immunocompromized patients with fungal colonization multiple organ failure and sepsis of unknown origin.Trial registrationClinicaltrials.gov number NCT01773876 More... »
PAGES399
http://scigraph.springernature.com/pub.10.1186/1745-6215-14-399
DOIhttp://dx.doi.org/10.1186/1745-6215-14-399
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1023377341
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/24261608
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Clinical Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antifungal Agents",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Candidemia",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Clinical Protocols",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Cross Infection",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Double-Blind Method",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Echinocandins",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Intensive Care Units",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Lipopeptides",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Micafungin",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Multiple Organ Failure",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Prospective Studies",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "AP-HP, H\u00f4pital Bichat, Medical and Infectious Diseases Intensive Care Unit, F-75018, Paris, France",
"id": "http://www.grid.ac/institutes/grid.411119.d",
"name": [
"University Grenoble 1, Intensive Care Unit, Albert Michallon Hospital, BP 217 38043, Cedex 9, Grenoble, France",
"Outcomerea Organization, Paris, France",
"AP-HP, H\u00f4pital Bichat, Medical and Infectious Diseases Intensive Care Unit, F-75018, Paris, France"
],
"type": "Organization"
},
"familyName": "Timsit",
"givenName": "Jean-Fran\u00e7ois",
"id": "sg:person.01215000253.20",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215000253.20"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Outcomerea Organization, Paris, France",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Intensive Care Unit, Saint Louis Hospital, Paris, France",
"Outcomerea Organization, Paris, France"
],
"type": "Organization"
},
"familyName": "Azoulay",
"givenName": "Elie",
"id": "sg:person.01352577613.57",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01352577613.57"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "TIMC-IMAG TheREx, UMR 5525 CNR-Joseph Fourier University, Parasitology-Mycology, Albert Michallon Hospital, Grenoble 1, BP 217, 38043, Cedex 9, Grenoble, France",
"id": "http://www.grid.ac/institutes/grid.410529.b",
"name": [
"TIMC-IMAG TheREx, UMR 5525 CNR-Joseph Fourier University, Parasitology-Mycology, Albert Michallon Hospital, Grenoble 1, BP 217, 38043, Cedex 9, Grenoble, France"
],
"type": "Organization"
},
"familyName": "Cornet",
"givenName": "Muriel",
"id": "sg:person.01334256475.46",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01334256475.46"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "IRSET INSERM U1085, Rennes Teaching Hospital, Parasitology-Mycology Laboratory, University Rennes 1, 35043, Cedex 9, Rennes, France",
"id": "http://www.grid.ac/institutes/grid.410368.8",
"name": [
"IRSET INSERM U1085, Rennes Teaching Hospital, Parasitology-Mycology Laboratory, University Rennes 1, 35043, Cedex 9, Rennes, France"
],
"type": "Organization"
},
"familyName": "Gangneux",
"givenName": "Jean-Pierre",
"id": "sg:person.01245726773.74",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01245726773.74"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "INSERM U663; Paris Descartes University, Department of Clinical Pharmacology, Georges Pompidou European Hospital; Assistance Publique-H\u00f4pitaux de Paris, Paris, France",
"id": "http://www.grid.ac/institutes/grid.508487.6",
"name": [
"INSERM U663; Paris Descartes University, Department of Clinical Pharmacology, Georges Pompidou European Hospital; Assistance Publique-H\u00f4pitaux de Paris, Paris, France"
],
"type": "Organization"
},
"familyName": "Jullien",
"givenName": "Vincent",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Outcomerea Organization, Paris, France",
"id": "http://www.grid.ac/institutes/None",
"name": [
"University Grenoble 1, U 823, Equipe 11 Outcome of mechanically ventilated patients and airway cancers, Paris, France",
"Outcomerea Organization, Paris, France"
],
"type": "Organization"
},
"familyName": "V\u00e9sin",
"givenName": "Aur\u00e9lien",
"id": "sg:person.0742332620.87",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0742332620.87"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Pharmacology University Grenoble 1, Albert Michallon Hospital, BP 217, 38043, Cedex 9, Grenoble, France",
"id": "http://www.grid.ac/institutes/grid.410529.b",
"name": [
"Pharmacology University Grenoble 1, Albert Michallon Hospital, BP 217, 38043, Cedex 9, Grenoble, France"
],
"type": "Organization"
},
"familyName": "Schir",
"givenName": "Edith",
"id": "sg:person.0730613330.09",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0730613330.09"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "AP-HP, H\u00f4pital Bichat, Medical and Infectious Diseases Intensive Care Unit, F-75018, Paris, France",
"id": "http://www.grid.ac/institutes/grid.411119.d",
"name": [
"AP-HP, H\u00f4pital Bichat, Medical and Infectious Diseases Intensive Care Unit, F-75018, Paris, France"
],
"type": "Organization"
},
"familyName": "Wolff",
"givenName": "Michel",
"id": "sg:person.01006646252.99",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01006646252.99"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1007/s00134-005-2794-y",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1042652182",
"https://doi.org/10.1007/s00134-005-2794-y"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00134-002-1540-y",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1046624930",
"https://doi.org/10.1007/s00134-002-1540-y"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s10096-008-0618-z",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1017978603",
"https://doi.org/10.1007/s10096-008-0618-z"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/2110-5820-1-37",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1033851533",
"https://doi.org/10.1186/2110-5820-1-37"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00134-012-2510-7",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1029002729",
"https://doi.org/10.1007/s00134-012-2510-7"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00134-008-1338-7",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1010625321",
"https://doi.org/10.1007/s00134-008-1338-7"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00134-005-2571-y",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1020082498",
"https://doi.org/10.1007/s00134-005-2571-y"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/cc10507",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1039151994",
"https://doi.org/10.1186/cc10507"
],
"type": "CreativeWork"
}
],
"datePublished": "2013-11-21",
"datePublishedReg": "2013-11-21",
"description": "BackgroundThe potential interest of antifungal treatment of non-immunocompromized patients with sepsis, extra-digestive Candida colonization and multiple organ failure is unknown. It represents three-quarters of antifungals prescribed in Intensive Care Units. It may allow early treatment of invasive fungal infection in the incubation phase but expose patients to unnecessary antifungal treatments with subsequent cost and fungal selection pressure. As early diagnostic tests for invasive candidiasis are still considered to be insufficient, the potential interest in this strategy needs to be demonstrated.MethodsThis prospective multicenter, double blind, randomized-controlled trial is conducted in 23 French Intensive Care Units. All adult patients, mechanically ventilated for more than four days with sepsis of unknown origin and with at least one extradigestive fungal colonization site and multiple organ failure are eligible for randomization. Patients with proven invasive candidiasis are not included. After a complete mycological screening, patients are allocated to receive micafungin 100\u00a0mg intravenously once a day or placebo for 14\u00a0days. We plan to enroll 260 patients. The main objective is to demonstrate that micafungin increases survival of patients without invasive candidiasis at day 28 as compared to placebo. Other outcomes include day 28 and 90 survival and organ failure evolution. Additionally, pharmacokinetics of micafungin in enrolled patients will be measured and evolution of fungal biomarkers and susceptibility profiles of infecting fungi will also be followed.DiscussionThis study will help to provide guidelines for treating non-immunocompromized patients with fungal colonization multiple organ failure and sepsis of unknown origin.Trial registrationClinicaltrials.gov number NCT01773876",
"genre": "article",
"id": "sg:pub.10.1186/1745-6215-14-399",
"inLanguage": "en",
"isAccessibleForFree": true,
"isPartOf": [
{
"id": "sg:journal.1297400",
"issn": [
"1468-6708",
"1745-6215"
],
"name": "Trials",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "1",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "14"
}
],
"keywords": [
"multiple organ failure",
"intensive care unit",
"organ failure",
"invasive candidiasis",
"care unit",
"antifungal treatment",
"day 28",
"unknown origin",
"French intensive care units",
"pharmacokinetics of micafungin",
"survival of patients",
"randomized-controlled trial",
"invasive fungal infections",
"unnecessary antifungal treatment",
"early diagnostic test",
"micafungin 100",
"prospective multicenter",
"adult patients",
"nosocomial sepsis",
"Candida colonization",
"ICU patients",
"study protocol",
"early treatment",
"patients",
"sepsis",
"placebo",
"fungal infections",
"susceptibility profiles",
"diagnostic tests",
"candidiasis",
"DiscussionThis study",
"micafungin",
"treatment",
"trials",
"three-quarters",
"survival",
"days",
"failure",
"subsequent costs",
"multicenter",
"colonization sites",
"potential interest",
"fungal biomarkers",
"pharmacokinetics",
"infection",
"biomarkers",
"outcomes",
"antifungals",
"randomization",
"screening",
"guidelines",
"incubation phase",
"study",
"protocol",
"colonization",
"units",
"test",
"origin",
"profile",
"pressure",
"objective",
"strategies",
"sites",
"selection pressure",
"main objective",
"interest",
"fungi",
"phase",
"cost",
"evolution",
"failure evolution"
],
"name": "EMPIRICUS micafungin versus placebo during nosocomial sepsis in Candida multi-colonized ICU patients with multiple organ failures: study protocol for a randomized controlled trial",
"pagination": "399",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1023377341"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1186/1745-6215-14-399"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"24261608"
]
}
],
"sameAs": [
"https://doi.org/10.1186/1745-6215-14-399",
"https://app.dimensions.ai/details/publication/pub.1023377341"
],
"sdDataset": "articles",
"sdDatePublished": "2022-06-01T22:13",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/article/article_614.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1186/1745-6215-14-399"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1745-6215-14-399'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1745-6215-14-399'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1745-6215-14-399'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1745-6215-14-399'
This table displays all metadata directly associated to this object as RDF triples.
279 TRIPLES
22 PREDICATES
117 URIs
101 LITERALS
19 BLANK NODES